Why the Office of Personnel Management Needs Access to Government Employee Health Plan Claims Data
Without knowledge of the exact amount providers billed and middlemen charged in fees, OPM can’t fix payment discrepancies.
Headache Disorders Have Been Part of the American Story for 250 Years
More than 40 million Americans live with migraine and other headache disorders. They include children trying to stay in school, workers trying to remain employed, parents caring for their families, veterans and first responders living with post-traumatic headache, and more.
presented by
The Power of Real World Data to Study Women’s Health at Scale
Veradigm examines key clinical trends, comorbidity profiles, and treatment trends across adolescence, reproductive years, and peri-/post-menopause. Download it today!
Too Many Prescriptions, Too Many Fatal Falls
The phenomenon of taking five or more medicines at the same time has become so common that it now has its own term – polypharmacy – and there is no doubt that it increases the risk of dizziness, confusion, and loss of balance.
‘Prior Authorization’ Has Become a Dirty Word in Healthcare, But it Might Be Medicare’s Smartest Path Forward
Since its inception, AI in prior auth has only been at work in the commercial healthcare marketplace. Now new innovative approaches that reframe prior auth as a resource instead of a roadblock have come to Medicare via the WISeR model.
Rural America Doesn’t Need Another Framework … It Needs Care by September 2026
Sixty million rural Americans aren’t asking for another strategic framework. They’re asking for care — accessible, affordable, and delivered with dignity.
Big Bets, Long Bets: Investing in the Power of Ideas
With science funding catapulted into the cultural conversation more than ever in the last year, it faces a critical inflection point. There is an opportunity to design a path forward that builds stability in the short term and opens doors in the long term for foundational and transformational science and technology solutions that will benefit our planet and its people.
presented by
Top 7 Modern AI-Powered EAP Providers for Global Workforces in 2026
Discover the top AI-powered EAP providers for 2026. Compare platforms like Kyan Health and Spring Health on triage speed, global reach, and clinical quality to transform workforce wellbeing.
Medicaid Helps Families — Like Mine — Live the Promise of “Life, Liberty, and the Pursuit of Happiness”
At the heart of this fight are the patients whose lives quite literally depend on Medicaid. But we are also fighting for the caregivers who show up every day, the children who rely on stability, the families who rally around their loved ones, and all those whose lives are shaped by access to care.
GLP-1s, Personalization, and Big Pharma Power Plays: What’s Really at Stake in the Eli Lilly Lawsuit
This lawsuit may look like a business dispute on the surface. But underneath, it’s about something much more important: the right of patients to receive personalized, affordable care.
Whole Eye Transplantation is No Longer Just Science Fiction
The technologies and techniques developed for eye transplantation and nerve regeneration may have significant translational potential for other biomedical needs including: spinal cord injury, central nervous system regeneration, retinal cell and tissue transplantation, and other forms of organ and tissue transplantation.
Supreme Court upholds ACA, dismissing constitutional challenge
The Supreme Court upheld the Affordable Care Act, dismissing the lawsuit brought by Texas, 17 other states and two individuals on the grounds that they were not able to prove they were harmed by the law. Industry stakeholders celebrated the court's long-awaited decision.
presented by
The Healthcare Payments Industry Has a Perception Problem
Healthcare payments are no longer about transactions. It’s about controlling the revenue cycle. And increasingly, that control is not sitting with ISOs.
DACA and the dashing of biotech dreams
A group of biotech executives, entrepreneurs, academics and researchers has sent an open letter to President Trump arguing that if DACA is not preserved, the economy (and by association the biotech industry) stands to lose and bigly.